Scott Daniel Cormack, President and CEO at ONCOGENEX PHARMACEUTICALS, INC. (OGXI), sold 4,571 shares at $2.69 ($12K) on 2015-06-12, disclosed to the SEC on 2015-06-16.
Open-market sale of $12k OGXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OGXI | SELL | 2015-05-21 | $14K | — | Filing → |
| OGXI | SELL | 2014-08-14 | $58K | — | Filing → |
| OGXI | SELL | 2014-03-18 | $57K | — | Filing → |